It is a pharma private limited company based in Shaikpet, Telangana, India, established in 2021.
2021 | Shaikpet, Telangana, India | ActiveSynac Pharmaceuticals Private Limited, a active private limited company, was established on 29 June 2021 in Shaikpet, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TG2021PTC152637. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.44 M and a paid-up capital of ₹1.44 M.
Employing 72 professional, Its leadership includes Nalla Hymavathi (Director), Nalla Surya Prakash Rao (Director), Mundla Maha Vishnu (Director). It holds ₹35.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.8-2-293/82/J-Iii/304-O. Plot No.304,, 3Rd Floor, Road No.78, Shaikpet, Telangana, 500033.
U24231TG2021PTC152637
152637
29 June 2021
₹1.44 M
₹1.44 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synac Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nalla Hymavathi | Director | 29 Jun 2021 | Current |
| Nalla Surya Prakash Rao | Director | 29 Jun 2021 | Current |
| Mundla Maha Vishnu | Director | 29 Jun 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synac Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 33.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Synac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹357,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2025 | Others | ₹7.50 M | Open |
| 03 Feb 2023 | Others | ₹35.00 Cr | Open |
Explore comprehensive loan charge details -
Synac Pharmaceuticals has a workforce of 72 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synac Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 7.50 M with Charge ID 101055040 was registered on 31 Jan 2025. was documented.
Synac Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others of Rs. 350.00 M registered on 03 Feb 2023 with Charge ID 100689812 was modified on 10 Apr 2024. was documented.
Progress on Synac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on A charge with Others amounted to Rs. 350.00 M with Charge ID 100689812 was registered on 03 Feb 2023. was documented.
Nalla Hymavathi was appointed as a Director was appointed as a Director on 29 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The CIN of Synac Pharmaceuticals Private Limited is U24231TG2021PTC152637.
Synac Pharmaceuticals Private Limited is headquartered at H.No.8-2-293/82/J-Iii/304-O. Plot No.304,, 3Rd Floor, Road No.78, Shaikpet, Telangana, 500033.
Synac Pharmaceuticals Private Limited was incorporated on 29 June 2021.
The current directors of Synac Pharmaceuticals Private Limited are
The primary industry of Synac Pharmaceuticals Private Limited is Manufacturing.
Synac Pharmaceuticals Private Limited is unlisted.
The authorized capital of Synac Pharmaceuticals Private Limited is ₹1.44 M, and the paid-up capital is ₹1.44 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX